In short
Bacopa monnieri is a traditional memory herb and one of the better-studied botanicals for cognition. A 2026 network meta-analysis of 29 trials found it improved memory, working and short-term in particular, with the largest effects at higher doses, and found no benefit for attention or processing speed. Like citicoline, it works cumulatively over weeks rather than as an acute lift. LAYER ZERO uses a concentrated 300 mg extract in the morning layer as a long-term memory contributor, and grades the dose honestly.
Bacopa is unusual among herbal ingredients: the evidence for it is genuinely decent. Which makes it all the more important to be precise about what that evidence supports, and what it does not.
01What Bacopa is
Bacopa monnieri, known in Ayurveda as Brahmi, is a herb with a long traditional use as a memory tonic. Its activity is attributed to compounds called bacosides. LAYER ZERO uses a 10:1 concentrated extract, meaning ten parts of raw herb reduced to one part extract, standardising the amount delivered rather than relying on variable plant material.
Definition · 10:1 extract
A concentrated extract where ten units of raw herb are processed down to one unit of extract. A 300 mg 10:1 Bacopa extract corresponds to roughly 3 g of raw herb, delivered in a consistent, concentrated form.
02What the evidence shows
The most current evidence is a 2026 systematic review and network meta-analysis pooling 29 randomised trials in over 2,000 healthy adults. It found that Bacopa improved memory, with the clearest effects on working and short-term memory, and that higher doses performed best. Notably, it found no significant benefit for sustained attention, selective attention, or processing speed.1 That last point matters: Bacopa is a memory ingredient, not a general sharpener.
This sits on top of older work pointing the same way. An earlier meta-analysis found Bacopa improved cognition, including a faster reaction time in some tests,2 and a systematic review concluded it had the most consistent effect on the free recall of learned information.3 Across a decade of trials, memory is where the signal is.
03It works cumulatively
Bacopa is not a same-day ingredient. The trials that show benefit run for eight to twelve weeks, because the effect builds with consistent use rather than arriving with a single dose. In this it behaves like citicoline: a quiet, cumulative contributor to where your cognition sits over time, not a lift you notice on the morning you take it. That is exactly the kind of ingredient a system built on baselines rather than peaks is designed around, which we explain in peak vs. baseline.
04The dose question
Here is the honest part. The largest effects in the 2026 analysis came from higher doses, and much of the strong trial evidence uses standardised extracts at the upper end. LAYER ZERO uses 300 mg of a 10:1 extract, placed in the morning stack as one contributor among several rather than as a single large stand-alone dose. We are clear that this is a supporting amount within a formula, not a replication of the highest-dose trial arms, and we grade its expected effect accordingly. What 300 mg of a 10 to 1 extract is, in plain terms, is the concentrate of roughly three grams of the raw herb, delivered every day, which is exactly the daily presence the cumulative mechanism rewards.
05What is still uncertain
Where the evidence stops
The 2026 network meta-analysis noted that few trials compared herbs head-to-head directly, which limits the strength of its rankings.1 Extracts and doses differ between studies, so results do not transfer perfectly to any one product. And the clear finding of no benefit for attention or processing speed is a real boundary on the claim: Bacopa supports memory over time, and we do not stretch it beyond that. There is no specific European authorised health claim for Bacopa.
06The research horizon
The strongest new bacopa result is comparative. A 2026 network meta-analysis pooled 29 randomised trials and 2,107 participants and ranked botanicals head to head for cognition in healthy adults: bacopa placed ahead of ginkgo, on pooled controlled data.4 A 2025 twelve week trial of a different bacopa extract added a new angle, finding reduced stress reactivity and fatigue after demanding cognitive tasks: the plant may steady the state that thinking happens in, not only the memory it produces.5 The pipeline ahead is unusually serious for a botanical: a US Veterans Affairs trial is testing bacopa for cognitive symptoms in Gulf War Illness, a registered trial at AIIMS is pairing it with blood metabolomics in early memory decline,6 and a new protocol is taking it into EEG, nerve conduction, and telomere-length endpoints in healthy ageing.7 When independent hospital systems start spending trial budgets on a plant, the plant has earned the attention. This page will carry the results as they land.
07How LAYER ZERO uses this
Bacopa and citicoline are the two cumulative, memory-and-cognition ingredients in the morning layer, the slow builders that sit beneath the faster-acting components. Their job is not the morning lift you feel, but the floor you operate from over weeks. That is the logic of LAYER ONE, and of the system: support that compounds, held to what the evidence actually shows.
In the system
LAYER ONE is the morning layer, built for focus and resilience. Bacopa is its cumulative memory component, paired with citicoline. To see how a day built on baselines rather than single peaks maps to your own schedule, the protocol builder takes about three minutes. Build your protocol →
Sources
Next in this thread
CiticolineThe other cumulative morning-layer nootropic, and how its evidence compares.→How we handle evidence. Every claim on this page is graded and linked to a primary source, and we say where the science is not yet settled. This page is educational and is not medical advice or a health claim about any product.